The global blood collection market size is projected to reach USD 7.22 billion by 2028 from USD 4.87 billion in 2021, at a CAGR of 5.8% during forecast period 2022-2028. Blood collection market is a routine process in which blood is collected from an individual to perform laboratory testing. Blood can be obtained from fingerstick or venous access devices. Mostly the blood is collected through venipuncture, process of puncturing the peripheral vein. The incidence of lifestyle diseases is also on the rise. Collected blood specimens are sent for diagnosis of various conditions like electrolytic imbalances, screening the risk factors like HDL and LDL, to monitor the therapeutics efficacy. Global blood collection devices market have plentiful of market players. Companies are focused on new product develepments and market expansions for strengthen the market share. For instance, in August 2012, Haemonetics Corporation acquired business assets of blood collection, filteration and processing product lines of Pall Corpration. On November 11, 2013, Grifols, a global healthcare company and producer of plasma therapies, acquired the transfusion diagnostics unit of Novartis. Furthermore, government organizations and non-government organizations are playing major role in providing awareness regarding life threatening diseases, blood transfusion, and blood donation. For example, in 2011, Government of South Africa and CDC entered into collaboration in order to develop national HIV research and clinical guidelines, conducting epidemiology training, and awareness programmes on TB and HIV.